| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 4-O-阿魏酰奎尼酸; 4-O-Feruloylquinic acid | CFN92392 | 2613-86-7 | C17H20O9 = 368.3 | 10mg | QQ客服：1457312923 |
| 香风草甙; Didymin | CFN92363 | 14259-47-3 | C28H34O14 = 594.6 | 20mg | QQ客服：2159513211 |
| Lobetyolinin; Lobetyolinin | CFN92357 | 142451-48-7 | C26H38O13 = 558.6 | 10mg | QQ客服：1457312923 |
| 党参炔醇; Lobetyol | CFN92356 | 136171-87-4 | C14H18O3 = 234.3 | 5mg | QQ客服：215959384 |
| 反式石竹烯; trans-Caryophyllene | CFN90502 | 87-44-5 | C15H24 = 204.36 | 20mg | QQ客服：1457312923 |
| 单宁酸; Tannic acid | CFN90501 | 1401-55-4 | C76H52O46 = 1701.2 | 20mg | QQ客服：1413575084 |
| 8-姜烯酚; 8-Shogaol | CFN92299 | 36700-45-5 | C19H28O3 = 304.4 | 20mg | QQ客服：1413575084 |
| 诃子林鞣酸; Chebulinic acid | CFN92296 | 18942-26-2 | C41H32O27 = 956.7 | 20mg | QQ客服：2159513211 |
| 灵芝酸C6甲酯; Methyl ganoderate C6 | CFN92292 | 105742-81-2 | C31H44O8 = 544.7 | 5mg | QQ客服：3257982914 |
| 灵芝酸H甲酯; Methyl ganoderate H | CFN92291 | 98665-11-3 | C33H46O9 = 586.7 | 5mg | QQ客服：2056216494 |
| 灵芝酸C6; Ganoderic acid C6 | CFN92290 | 105742-76-5 | C30H42O8 = 530.7 | 20mg | QQ客服：1457312923 |
| 白杨素 6-C-葡萄糖 8-C-阿拉伯糖苷; Chrysin 6-C-glucoside 8-C-arabinoside | CFN92285 | 185145-34-0 | C26H28O13 = 548.5 | 5mg | QQ客服：215959384 |
| 白杨素 6-C-阿拉伯糖 8-C-葡萄糖苷; Chrysin 6-C-arabinoside 8-C-glucoside | CFN92284 | 185145-33-9 | C26H28O13 = 548.5 | 5mg | QQ客服：1413575084 |
| Delta 5-avenasterol; Delta 5-avenasterol | CFN92239 | 18472-36-1 | C29H48O = 412.7 | 5mg | QQ客服：3257982914 |
| 灵芝烯酸C; Ganoderenic acid C | CFN92238 | 100665-42-7 | C30H44O7 = 516.7 | 10mg | QQ客服：3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)